Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing CPSIs Q4 Earnings Report A Detailed Review

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
EEFT stock news
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

CPSI‘s Q4 Earnings Report: A Closer Look

On February 29, 2024, CPSI (NASDAQ:CPSI) unveiled its Q4 earnings, providing valuable insights for investors.

Earnings Surpass Expectations: CPSI exceeded estimated earnings by 3.0%, boasting an impressive EPS of $0.36 compared to the projected $0.35.

Revenue Growth: The company experienced a notable $2.64 million increase in revenue compared to the same period last year.

Analyzing Past Performance

Looking back at previous quarters, CPSI has shown a mixed bag of results. While the company outperformed EPS estimates by $0.03 in the last quarter, it faced an 11.0% decrease in share price the following day. Here’s a summary of CPSI’s past performance:

Quarter EPS Estimate EPS Actual Revenue Estimate Revenue Actual
Q3 2023 0.42 0.45 $85.10M $82.71M
Q2 2023 0.58 0.40 $86.07M $84.62M
Q1 2023 0.70 0.58 $84.63M $86.23M
Q4 2022 0.58 0.61 $82.10M $83.22M

For a more comprehensive look at CPSI’s earnings releases, investors are encouraged to consult their earnings calendar.

This data reflects CPSI’s recent financial performance and market expectations, providing valuable insights for investors moving forward.

CPSI Stock Price Drops During Regular Trading Hours But Shows Signs of Recovery in After-Hours Trading

On February 29, 2024, CPSI stock experienced a slight decrease in its price during regular trading hours, closing at $8.86. The stock was trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a bearish trend in the stock’s performance.

The price of CPSI shares decreased by $0.04, representing a 0.45% drop from the previous market close. Despite this decline, the stock showed signs of potential recovery as it rose by $1.24 in after-hours trading. This after-hours gain could be attributed to positive news or developments related to the company that were announced after the market closed.

CPSI Stock Performance Analysis: Revenue Increases but Net Income Declines – February 29, 2024

On February 29, 2024, CPSI stock experienced mixed performances based on the financial data provided by CNN Money. The company reported a total revenue of $292.55 million for the past year, which represented a 4.25% increase compared to the previous year. However, the total revenue remained flat at $82.71 million in the third quarter of the fiscal year. The net income for CPSI was $15.56 million for the past year, a 13.68% decrease from the previous year, and further declined to -$3.48 million in the third quarter, a significant decrease of 25.5% compared to the previous quarter. The earnings per share (EPS) for CPSI was $1.08 for the past year, reflecting a decrease of 13.9% compared to the previous year, and further decreased to -$0.24 in the third quarter, representing a 25.45% decrease from the previous quarter. Overall, the financial performance of CPSI on February 29, 2024, suggested a mixed picture for investors. Investors may need to closely monitor the company’s future financial reports and developments to make informed decisions regarding CPSI stock.

Tags: CPSI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Fitness and app

Title Xponential Fitness Q4 Earnings Report Insights for Investors

Finance_Capitalization

Analyzing Organogenesis Holdings Incs Q4 Earnings Performance

Finance_Accounting (2)

Elastic Corporations Q3 Financial Report Surprising Stock Drop Despite Exceeding Expectations

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com